YTL Corporation Berhad (KLSE:YTL)
Malaysia · Delayed Price · Currency is MYR 2.520
+0.040 (1.61%)
At close: Aug 4, 2025
Sage Therapeutics Income Statement
Financials in millions MYR. Fiscal year is July - June.
Millions MYR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2016 - 2020 |
| 31,384 | 30,491 | 29,616 | 24,242 | 17,270 | 19,178 | Upgrade | |
Revenue Growth (YoY) | -0.26% | 2.95% | 22.17% | 40.36% | -9.95% | 6.27% | Upgrade |
Selling, General & Admin | 2,236 | 2,236 | 2,000 | 1,783 | 1,664 | 1,900 | Upgrade |
Other Operating Expenses | 22,776 | 21,208 | 22,979 | 19,761 | 13,829 | 15,272 | Upgrade |
Total Operating Expenses | 25,012 | 23,444 | 24,979 | 21,544 | 15,493 | 17,172 | Upgrade |
Operating Income | 6,372 | 7,047 | 4,637 | 2,698 | 1,777 | 2,007 | Upgrade |
Interest Expense | -2,427 | -2,625 | -2,328 | -1,580 | -1,541 | -1,845 | Upgrade |
Net Interest Expense | -2,427 | -2,625 | -2,328 | -1,580 | -1,541 | -1,845 | Upgrade |
Income (Loss) on Equity Investments | 501.14 | 410.76 | 420.05 | 442.05 | 395.52 | 257.2 | Upgrade |
EBT Excluding Unusual Items | 4,446 | 4,833 | 2,729 | 1,559 | 631.79 | 419.29 | Upgrade |
Total Merger & Restructuring Charges | - | - | - | -11.9 | - | - | Upgrade |
Other Unusual Items | - | - | - | 270.82 | - | - | Upgrade |
Pretax Income | 4,446 | 4,833 | 2,729 | 1,818 | 631.79 | 419.29 | Upgrade |
Income Tax Expense | 959.16 | 948.24 | 606.77 | 369 | 959.18 | 414.64 | Upgrade |
Earnings From Continuing Ops. | 3,487 | 3,885 | 2,122 | 1,449 | -327.38 | 4.66 | Upgrade |
Minority Interest in Earnings | -1,620 | -1,744 | -1,027 | -754.24 | -40.28 | -193.88 | Upgrade |
Net Income | 1,866 | 2,141 | 1,096 | 695.11 | -367.66 | -189.22 | Upgrade |
Net Income to Common | 1,866 | 2,141 | 1,096 | 695.11 | -367.66 | -189.22 | Upgrade |
Net Income Growth | -13.40% | 95.36% | 57.63% | - | - | - | Upgrade |
Shares Outstanding (Basic) | 11,024 | 10,973 | 10,964 | 10,964 | 10,864 | 10,649 | Upgrade |
Shares Outstanding (Diluted) | 11,203 | 11,181 | 11,025 | 11,018 | 10,864 | 10,649 | Upgrade |
Shares Change (YoY) | 0.35% | 1.42% | 0.07% | 1.42% | 2.02% | 0.75% | Upgrade |
EPS (Basic) | 0.17 | 0.20 | 0.10 | 0.06 | -0.03 | -0.02 | Upgrade |
EPS (Diluted) | 0.17 | 0.19 | 0.10 | 0.06 | -0.03 | -0.02 | Upgrade |
EPS Growth | -13.73% | 92.55% | 57.53% | - | - | - | Upgrade |
Free Cash Flow | 719.19 | 2,673 | 2,592 | -362.19 | 1,099 | 1,463 | Upgrade |
Free Cash Flow Per Share | 0.06 | 0.24 | 0.23 | -0.03 | 0.10 | 0.14 | Upgrade |
Dividend Per Share | 0.045 | 0.045 | 0.040 | 0.030 | 0.025 | - | Upgrade |
Dividend Growth | 12.50% | 12.50% | 33.33% | 20.00% | - | - | Upgrade |
Profit Margin | 5.95% | 7.02% | 3.70% | 2.87% | -2.13% | -0.99% | Upgrade |
Free Cash Flow Margin | 2.29% | 8.77% | 8.75% | -1.49% | 6.37% | 7.63% | Upgrade |
EBITDA | 8,390 | 8,705 | 6,265 | 4,313 | 3,435 | 3,576 | Upgrade |
EBITDA Margin | 26.73% | 28.55% | 21.15% | 17.79% | 19.89% | 18.64% | Upgrade |
D&A For EBITDA | 2,018 | 1,658 | 1,629 | 1,615 | 1,658 | 1,569 | Upgrade |
EBIT | 6,372 | 7,047 | 4,637 | 2,698 | 1,777 | 2,007 | Upgrade |
EBIT Margin | 20.30% | 23.11% | 15.66% | 11.13% | 10.29% | 10.46% | Upgrade |
Effective Tax Rate | 21.57% | 19.62% | 22.23% | 20.29% | 151.82% | 98.89% | Upgrade |
Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Utility template. Financial Sources.